Dapo, Reign Marie .
HRN: 22-83-73 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/23/2023
CEFUROXIME 750MG (VIAL)
03/23/2023
03/30/2023
IV
227mg
TID
Empiric
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes